B Group, Inc. Portfolio Holdings

B Group, Inc.

  • $136 Billion
  • Q3 2025

B Group, Inc. has filed its 13F form on November 14, 2025 for Q3 2025 where it was disclosed a total value porftolio of $136 Billion distributed in 20 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Adma Biologics, Inc. with a value of $35.4B, Zai Lab LTD with a value of $13.6B, Akero Therapeutics, Inc. with a value of $11B, Cellectis S.A. with a value of $9.35B, and Taysha Gene Therapies, Inc. with a value of $5.89B.

Examining the 13F form we can see an increase of $6.01B in the current position value, from $130B to 136B.

B Group, Inc. is based out at Dallas, TX

Below you can find more details about B Group, Inc. portfolio as well as his latest detailed transactions.

Portfolio value $136 Billion
Healthcare: $111 Billion
Technology: $14 Billion

Stock Holdings Table Market Cap. of Under $50 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$0
$4.46 Billion 3.28% of portfolio
3,000,000
Q3 2025 New

Summary

  • Portfolio
  • No. of Stocks 20
  • Current Value $136 Billion
  • Prior Value $130 Billion
  • Filing
  • Period Q3 2025
  • Filing Date November 14, 2025
  • Form Type 13F-HR
  • Activity in Q3 2025
  • New Purchases 2 stocks
  • Additional Purchases 4 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 3 stocks
Track This Portfolio

Track B Group, Inc. Portfolio

Follow B Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of B Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on B Group, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email